Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,764 public trials 2,078 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

NCT03212274

Conditions
Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
Locations
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

NCT05614102

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
Locations
  • Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's Denver, Colorado, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • START | San Antonio San Antonio, Texas, United States
  • Antwerp University Hospital | Oncology Department Antwerp, Belgium
View all 21 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

NCT04083599

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +36 more
Locations
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Cancer & Blood Specialty Clinic Los Alamitos, California, United States
  • Moores Cancer Center at the UC San Diego Health San Diego, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Active, Not Recruiting

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

NCT03528694

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Research Site Auchenflower, Australia
  • Research Site Box Hill, Australia
  • Research Site Brisbane, Australia
  • Research Site Kogarah, Australia
View all 120 locations
View Trial Details
Active, Not Recruiting

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00334815

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +15 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Saint Bernards Regional Medical Center Jonesboro, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
View all 61 locations
View Trial Details

Related conditions